A study by Tomita et al. [43] that included 14 ILD patients with NSCLC reported that high KL-6 levels exhibited a trend indicating a worse prognosis compared with low KL-6 levels (p = 0.063). This evidence concerns the gene MUC1 and interstitial lung disease.